Showing results (1511-1520 of 1,878) with videos related to

Sort By:
Pageof 188
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2016
Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor MimicMarkus Hutterer, Yvonne Ebner, Markus J Riemenschneider, et al.
The New Phytologist|February 27, 2025
Plant species richness promotes the decoupling of leaf and root defence traits while species-specific responses in physical and chemical defences are rareLeonardo Bassi, Justus Hennecke, Cynthia Albracht, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 26, 2011
To share or not to share: a randomized trial of consent for data sharing in genome researchAmy L McGuire, Jill M Oliver, Melody J Slashinski, et al.
American Journal of Medical Genetics. Part A|September 12, 2012
Beyond Gómez-López-Hernández syndrome: recurring phenotypic themes in rhombencephalosynapsisHannah M Tully, Jennifer C Dempsey, Gisele E Ishak, et al.
Kidney International|September 20, 2025
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)Jürgen Floege, Jonathan Barratt, H Terence Cook, et al.
Nature Plants|November 24, 2020
The structural basis of Rubisco phase separation in the pyrenoidShan He, Hui-Ting Chou, Doreen Matthies, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
gamma-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonistsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
ESMO Open|May 28, 2025
Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinomaR S Finn, M Kudo, P Merle, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2016
A repeat protein links Rubisco to form the eukaryotic carbon-concentrating organelleLuke C M Mackinder, Moritz T Meyer, Tabea Mettler-Altmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2024
Expanded profiling of WD repeat domain 5 inhibitors reveals actionable strategies for the treatment of hematologic malignanciesChristian T Meyer, Brianna N Smith, Jing Wang, et al.
Pageof 188